VERU INC. Effective Income Tax Rate Reconciliation Gilti Amount
VERU INC. (VERU) reported Effective Income Tax Rate Reconciliation Gilti Amount of $500.61 thousand for the 12-month period ending 2024-09-30, per its 10-K filed 2024-12-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount · last filed 2024-12-16
- VERU INC. effective income tax rate reconciliation gilti amount for the quarter ending 2024-06-30 was $302.15K.
- VERU INC. effective income tax rate reconciliation gilti amount for the quarter ending 2023-06-30 was -$24.69K, a 290.09% decline year-over-year.
- VERU INC. effective income tax rate reconciliation gilti amount for the quarter ending 2022-06-30 was $12.99K.
- VERU INC. effective income tax rate reconciliation gilti amount for fiscal 2024 was $500.61K.
- VERU INC. effective income tax rate reconciliation gilti amount for fiscal 2023 was -$24.69K, a 200.00% decline from fiscal 2022.
- VERU INC. effective income tax rate reconciliation gilti amount for fiscal 2022 was $24.69K.
| Period end | Effective Income Tax Rate Reconciliation Gilti Amount 3 month | Effective Income Tax Rate Reconciliation Gilti Amount 3 month as first filed | Effective Income Tax Rate Reconciliation Gilti Amount 9 month | Effective Income Tax Rate Reconciliation Gilti Amount 9 month as first filed | Effective Income Tax Rate Reconciliation Gilti Amount 12 month | Effective Income Tax Rate Reconciliation Gilti Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-09-30 | $500.61K 10-K · filed 2024-12-16 | |||||
| 2024-06-30 | $302.15K 10-Q · filed 2024-08-08 | $302.15K 10-Q · filed 2024-08-08 | ||||
| 2023-09-30 | -$24.69K 10-K · filed 2024-12-16 | $24.69K 10-K · filed 2023-12-08 | ||||
| 2023-06-30 | -$24.69K 10-Q · filed 2024-08-08 | $24.69K 10-Q · filed 2023-08-10 | -$24.69K 10-Q · filed 2024-08-08 | $24.69K 10-Q · filed 2023-08-10 | ||
| 2022-09-30 | $24.69K 10-K/A · filed 2024-04-01 | |||||
| 2022-06-30 | $12.99K 10-Q/A · filed 2023-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |